BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 8, 2002
View Archived Issues
Imatinib mesilate may modify the natural history of chronic myelogenous leukemia
Read More
SPI-77 is safe and more effective than carboplatin in dogs with osteosarcoma
Read More
Neuroprotective peptide humanin produced in vivo
Read More
Synergistic antitumor effect for irofulven combined with mitomycin D or thiotepa
Read More
Improved efficacy of calcipotriol plus betamethasone in psoriasis vulgaris
Read More
Imiquimod 5% cream reported to be highly effective against nongenital warts
Read More
Fujisawa and Sumitomo enter collaboration for oral carbapenem antibiotics
Read More
Flemington Pharmaceutical now known as NovaDel Pharma
Read More
CIMA to develop fast-dissolve version of Allegra
Read More
Key Oxcyte preclinical studies completed
Read More
SIGA and TransTech join forces to develop therapeutics for infectious diseases
Read More
Patient enrollment met in Preos POWER trial
Read More
Immune Network updates dapsone progress
Read More
Keryx extends manufacturing and negotiating rights for KRX-101
Read More
Pharmion launches Innohep
Read More
Activity of new pyrrolopyrimidine oxazolidinones against Gram-positive microorganisms
Read More
New Pharmacia oxazolidinone analogues compare favorably with linezolid
Read More
Multivalent aminoglycosides may be useful against aminoglycoside-resistant infections
Read More
New antibacterial beta-carboline compounds covered by GSK patent
Read More
NeoRx describes bone-selective metal complexes for diagnostic and therapeutic applications
Read More
Novel NK1 antagonists and their use in depression and emesis
Read More
GSK develops new series of 5-HT7 antagonists
Read More
Roche researchers identify new HDAC inhibitors
Read More
Novel GSK-3beta inhibitors prepared and tested at Mitsubishi Pharma
Read More
Preferential dopamine D3 antagonist with promising preclinical antipsychotic profile
Read More
Karo Bio presents thyroid receptor antagonists with potential in arrhythmia and other disorders
Read More
E-6006 citrate effective in rat model of obsessive-compulsive disorder
Read More
GSK 5-HT1B receptor antagonist effective in animal models of depression and anxiety
Read More
Remodulin approved in Canada
Read More